Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Held

Showing results (31-40 of 46) with videos related to

Pageof 5
Sort By:
Circulation|June 29, 2017
Risk for Major Bleeding in Patients Receiving Ticagrelor Compared With Aspirin After Transient Ischemic Attack or Acute Ischemic Stroke in the SOCRATES Study (Acute Stroke or Transient Ischemic Attack Treated With Aspirin or Ticagrelor and Patient Outcomes)J Donald Easton, Maria Aunes, Gregory W Albers, et al.
The Lancet. Neurology|February 28, 2017
Efficacy and safety of ticagrelor versus aspirin in acute stroke or transient ischaemic attack of atherosclerotic origin: a subgroup analysis of SOCRATES, a randomised, double-blind, controlled trialPierre Amarenco, Gregory W Albers, Hans Denison, et al.
Stroke|July 20, 2017
Ticagrelor Versus Aspirin in Acute Embolic Stroke of Undetermined SourcePierre Amarenco, Gregory W Albers, Hans Denison, et al.
European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery|December 24, 2017
Outcomes of Patients with Critical Limb Ischaemia in the EUCLID TrialLars Norgren, Manesh R Patel, William R Hiatt, et al.
JAMA Network Open|January 16, 2019
Polyvascular Disease and Risk of Major Adverse Cardiovascular Events in Peripheral Artery Disease: A Secondary Analysis of the EUCLID TrialJ Antonio Gutierrez, Hillary Mulder, W Schuyler Jones, et al.
Circulation|November 15, 2016
Ticagrelor Compared With Clopidogrel in Patients With Prior Lower Extremity Revascularization for Peripheral Artery DiseaseW Schuyler Jones, Iris Baumgartner, William R Hiatt, et al.
Vascular Medicine (London, England)|July 12, 2018
Ticagrelor versus clopidogrel in patients with symptomatic peripheral artery disease and prior coronary artery disease: Insights from the EUCLID trialJeffrey S Berger, Beth L Abramson, Renato D Lopes, et al.
Journal of the American College of Cardiology|December 22, 2018
Cardiovascular and Limb Outcomes in Patients With Diabetes and Peripheral Artery Disease: The EUCLID TrialCecilia C Low Wang, Juuso I Blomster, Gretchen Heizer, et al.
Circulation|October 20, 2004
Mortality and morbidity reduction with Candesartan in patients with chronic heart failure and left ventricular systolic dysfunction: results of the CHARM low-left ventricular ejection fraction trialsJames B Young, Mark E Dunlap, Marc A Pfeffer, et al.
Circulation|September 1, 2016
Prevention of Stroke with Ticagrelor in Patients with Prior Myocardial Infarction: Insights from PEGASUS-TIMI 54 (Prevention of Cardiovascular Events in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin-Thrombolysis in Myocardial Infarction 54)Marc P Bonaca, Shinya Goto, Deepak L Bhatt, et al.
Pageof 5

Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
Circulation|June 29, 2017
Risk for Major Bleeding in Patients Receiving Ticagrelor Compared With Aspirin After Transient Ischemic Attack or Acute Ischemic Stroke in the SOCRATES Study (Acute Stroke or Transient Ischemic Attack Treated With Aspirin or Ticagrelor and Patient Outcomes)J Donald Easton, Maria Aunes, Gregory W Albers, et al.
The Lancet. Neurology|February 28, 2017
Efficacy and safety of ticagrelor versus aspirin in acute stroke or transient ischaemic attack of atherosclerotic origin: a subgroup analysis of SOCRATES, a randomised, double-blind, controlled trialPierre Amarenco, Gregory W Albers, Hans Denison, et al.
Stroke|July 20, 2017
Ticagrelor Versus Aspirin in Acute Embolic Stroke of Undetermined SourcePierre Amarenco, Gregory W Albers, Hans Denison, et al.
European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery|December 24, 2017
Outcomes of Patients with Critical Limb Ischaemia in the EUCLID TrialLars Norgren, Manesh R Patel, William R Hiatt, et al.
JAMA Network Open|January 16, 2019
Polyvascular Disease and Risk of Major Adverse Cardiovascular Events in Peripheral Artery Disease: A Secondary Analysis of the EUCLID TrialJ Antonio Gutierrez, Hillary Mulder, W Schuyler Jones, et al.
Circulation|November 15, 2016
Ticagrelor Compared With Clopidogrel in Patients With Prior Lower Extremity Revascularization for Peripheral Artery DiseaseW Schuyler Jones, Iris Baumgartner, William R Hiatt, et al.
Vascular Medicine (London, England)|July 12, 2018
Ticagrelor versus clopidogrel in patients with symptomatic peripheral artery disease and prior coronary artery disease: Insights from the EUCLID trialJeffrey S Berger, Beth L Abramson, Renato D Lopes, et al.
Journal of the American College of Cardiology|December 22, 2018
Cardiovascular and Limb Outcomes in Patients With Diabetes and Peripheral Artery Disease: The EUCLID TrialCecilia C Low Wang, Juuso I Blomster, Gretchen Heizer, et al.
Circulation|October 20, 2004
Mortality and morbidity reduction with Candesartan in patients with chronic heart failure and left ventricular systolic dysfunction: results of the CHARM low-left ventricular ejection fraction trialsJames B Young, Mark E Dunlap, Marc A Pfeffer, et al.
Circulation|September 1, 2016
Prevention of Stroke with Ticagrelor in Patients with Prior Myocardial Infarction: Insights from PEGASUS-TIMI 54 (Prevention of Cardiovascular Events in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin-Thrombolysis in Myocardial Infarction 54)Marc P Bonaca, Shinya Goto, Deepak L Bhatt, et al.
Pageof 5